Dual‑Material 3D Printing Platform for Perfusable Tissue Scaffolds (Dual Printing Additive Manufacturing of 3D Scaffolds with Channel Diameters Ranging from 100–500 Microns, Tech ID: 18‑038)
Technology Overview: This technology enables dual‑material additive manufacturing of 3D scaffolds with precisely controlled channel diameters suitable for tissue perfusion and vascularization. The system prints structural and sacrificial materials in a coordinated manner, enabling formation of interconnected microchannels within biocompatible scaffolds. This capability is critical for developing functional engineered tissues with nutrient and oxygen transport.
Industry Pain Point: Many tissue scaffolds lack perfusable channels, limiting tissue viability and scale.
NJIT Solution: This platform delivers precise, integrated channel networks to support tissue survival and function.
Key Features & Advantages
- Precisely controlled 100–500 µm channels
- Dual‑material additive manufacturing approach
- Enables perfusable tissue constructs
- Compatible with tissue engineering workflows
Development Stage: TRL 4–5 – Laboratory validation completed.
Target Markets
- Tissue engineering and regenerative medicine
- Bioprinting platforms
- In‑vitro tissue models
Market Opportunity
- Global bioprinting market (2026): ~$2.8B
- CAGR: ~18–20%
- Projected market size (2035): ~$12–14B
Commercial & IP Details
Inventors: Murat Guvendiren, Shen Ji